IDXX

IDEXX LABORATORIES INC /DE

IDXX · CIK 874716 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$4.3B
20182025
Net Income$1.1B
20182025
Operating CF$1.2B
20182025
Free Cash Flow$1.1B
20182025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Revenue$4.3B$3.9B$3.7B$3.4B$3.2B$2.7B$0.6B$0.5B
Cost of Revenue$1.6B$1.5B$1.5B$1.4B$1.3B$1.1B$1.0B$1.0B
Gross Profit$2.7B$2.4B$2.2B$2.0B$1.9B$1.6B$0.3B$0.3B
R&D Expense$0.3B$0.2B$0.2B$0.3B$0.2B$0.1B$0.1B$0.1B
SG&A Expense
Operating Income$1.4B$1.1B$1.1B$0.9B$0.9B$0.7B$0.1B$0.1B
Net Income$1.1B$0.9B$0.8B$0.7B$0.7B$0.6B$0.1B$0.1B
EPS (Basic)$13.17$10.77$10.17$8.12$8.74$6.82$1.05$0.99
EPS (Diluted)$13.08$10.67$10.06$8.03$8.60$6.71$1.04$0.98

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Total Assets$3.4B$3.3B$3.3B$2.7B$2.4B$2.3B$1.8B$1.5B
Current Assets$1.4B$1.4B$1.5B$1.1B$1.0B$1.1B$0.7B$0.7B
Cash & Equivalents$0.2B$0.3B$0.5B$0.1B$0.1B$0.4B$0.1B$0.1B
Total Liabilities$1.7B$1.7B$1.8B$2.1B$1.7B$1.7B$1.7B$1.5B
Current Liabilities$1.1B$1.1B$1.0B$1.2B$0.8B$0.6B$0.7B$0.8B
Stockholders' Equity$1.6B$1.6B$1.5B$0.6B$0.7B$0.6B$0.2B$-0.0B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Operating Cash Flow$1.2B$0.9B$0.9B$0.5B$0.8B$0.6B$0.5B$0.4B
Investing Cash Flow$-0.1B$-0.2B$-0.1B$-0.2B$-0.3B$-0.1B$-0.2B
Capital Expenditures$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.2B$0.1B
Financing Cash Flow$-1.2B$-0.9B$-0.4B$-0.4B$-0.7B$-0.2B$-0.3B